You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023188010
Dec 202348011
Jan 20248906
Feb 20243403
Mar 20243403
Apr 20242600
May 20242600
Jun 20243000
Jul 20242802
Aug 20242602
Sep 20243604
Oct 20242202
Nov 20244005
Dec 202430010
Jan 20252607
Feb 2025802
Mar 2025001
Apr 2025003
May 2025007
Jun 2025102
Total692080